Approval · Notice of Compliance 19271 · 2017
OFEV: Notice of Compliance 19271
Issued April 25, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19271
- Date
- April 25, 2017
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosing strategy for patients with mild hepatic impairment child pugh a). updated safety informaition regarding patients with hepatic impairment
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OFEV | Not yet assigned | — |
Medicinal ingredients
- NINTEDANIB 100 MG per CAP
- NINTEDANIB 150 MG per CAP